← All trials
NCT02903030
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2016
- Primary completion
- Aug 1, 2017
- Completion date
- Aug 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 12
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Ohio State UniversityLead sponsor
- Ohio State UniversityOverall official - principal investigator
- Ohio State UniversityReponsible party - principal investigator
- Autism Treatment NetworkCollaborator
- Autism SpeaksCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.